Advertisement

The Latest

As health systems face pressure to keep pace with a rapidly expanding body of cancer innovation, oncology leaders are turning to AI, increasingly weighing how the technology can support — rather than replace — care teams at every level. Richard…

Amid financial pressures, it’s easy for leaders to rely solely on return on investment as the primary measure for success, but for Frantz Berthaud, “return on humanity” is just as important to measure. “It’s a point of orientation and a…

Altamonte Springs, Fla.-based AdventHealth has expanded the footprint of its cancer institute with the opening of a new cancer center in Winter Garden, Fla. AdventHealth Winter Garden will begin treating patients at the new facility July 27, according to a…

The FDA has granted full approval for selpercatnib in the treatment of advanced cancer among patients ages 2 and older who carry a rare genetic alteration. Selpercatinib, also known as Retevmo, targets and “turns off” the RET gene fusion to…

Behavioral health utilization rose 62.6 percent between 2018 and 2024 and the national mental health workforce is on pace to fall nearly 100,000 full-time counselors short of demand by 2038.  Emergency departments are absorbing much of that strain: hospitals reporting…

Sep 25, 2026 11:00 AM - 12:00 PM CDT

Presented by:

Presented by
Presenters:
  • Sara Gotheridge, MD, Chief Medical Officer, Array
  • Dominique Dietz, Director, Virtual Behavioral Health, OSF HealthCare
  • Earl E. Walker, Jr., Ed.D., MBA, FACHE, PMP, CSSGB, Senior Director, Behavioral Health, Bayhealth
  • Tracey Izzard, Vice President, Enterprise Behavioral Health, Sentara Health
  • Julie Swann MBA, MHA, BSN, RN, NEA-BC, VP Patient Care Services and Chief Nursing Officer, Emory Saint Joseph’s Hospital

Tempus AI has agreed to acquire the cancer genomics company Personalis in a deal valued at about $1.5 billion, the companies announced July 20. The acquisition builds on a partnership the two companies formed in November 2023, when Tempus invested…

Abbott is investigating a cyber incident involving unauthorized access to a limited number of internal systems in its cancer diagnostics business. The incident does not affect business operations, product availability, manufacturing, lab operations or the company’s ability to serve patients,…

Boston-based Dana-Farber Cancer Institute, Columbus-based Ohio State University Comprehensive Cancer Center — James Cancer Hospital and Solove Research Institute, and the Inflammatory Breast Cancer Research Foundation have launched a joint research initiative on metastatic inflammatory breast cancer. The initiative will…

By decentralizing clinical trials, Rochester, Minn.-based Mayo Clinic increased enrollment of patients from rural communities and underserved racial and ethnic populations, according to a study published June 5 in JAMA Network Open.  Mayo Clinic researchers evaluated data from 7,469 patients…

Nearly half of U.S. hospitals now offer remote patient monitoring (RPM) services. The next challenge is turning those programs into better chronic disease management, stronger patient engagement and measurable outcomes. In fact, the Centers for Medicare and Medicaid Services (CMS)…

Aug 20, 2026 11:00 AM - 12:00 PM CDT

Presented by:

Presented by
Presenters:
  • Lucienne Ide, MD, PhD, Chief Medical Officer, Health Recovery Solutions
  • Lindsey Valenzuela, PharmD, APh, BCACP, VP Population Health Integration, Desert Oasis Healthcare
  • Zsolt Kulcsar DO, MPH, MBA, CPE, Vice President Virtual Health, Emory Healthcare
Advertisement